上海莼試生物技術(shù)有限公司
主營(yíng)產(chǎn)品: ELISA試劑盒,ELISA試劑盒價(jià)格,ELISA試劑盒報(bào)價(jià) |
聯(lián)系電話
13585831301
公司信息
- 聯(lián)系人:
- 李小姐
- 電話:
- 021-59541103
- 手機(jī):
- 13585831301
- 售后電話:
- 13585831301
- 傳真:
- 021-60443211
- 地址:
- 上海市嘉定區(qū)嘉羅公路1661號(hào)
- 郵編:
參考價(jià) | 面議 |
- 型號(hào)
- 品牌
- 廠商性質(zhì) 經(jīng)銷商
- 所在地 上海市
更新時(shí)間:2017-07-24 10:14:33瀏覽次數(shù):326
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是環(huán)保在線上看到的信息,謝謝!
產(chǎn)品名稱 | 焦磷酸銅10102-90-6操作方法 |
英文名稱 | Copper pyrophosphate |
發(fā)貨 | 上海 |
焦磷酸銅10102-90-6操作方法特點(diǎn):
1.現(xiàn)貨直銷,當(dāng)天下單,當(dāng)天發(fā)貨。雷帕霉素3123-88-9操作方法
2.產(chǎn)品優(yōu)質(zhì),到貨快,免費(fèi)快遞。
全、新、優(yōu)、品、好五大特點(diǎn):
全:公司提供上萬(wàn)種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
品:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等國(guó)內(nèi)外。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
公司提供的質(zhì)保證,貨源充足。嚴(yán)格的質(zhì)量控制體系,包括:優(yōu)級(jí)純,分析純,化學(xué)純,試劑級(jí),基準(zhǔn)試劑,實(shí)驗(yàn)純,教學(xué)試劑,高純?cè)噭V純,光譜純,電子純。各種包裝規(guī)格,并可提供包裝定制,咨詢訂購(gòu)。
英文名稱: Copper pyrophosphate
其他英文名稱: Diphosphoric acid copper salt
產(chǎn)品規(guī)格: AR,96%
包 裝: 500克
:10102-90-6
Cu2P2O7=301.04
級(jí)別:AR
含量:≥96.0%
氯化物:≤0.01%
硫酸鹽:≤0.01%
重金屬:≤10ppm
性狀:藍(lán)色粉末,溶于酸,不溶于水
用途:生化研究。
保存:RT,保質(zhì)期5年
62-46-4 HPLC≥98%;20mg 訂購(gòu)|咨詢
9007-28-7 HPLC≥98%;20mg 訂購(gòu)|咨詢
331-39-5 HPLC≥98%;20mg 訂購(gòu)|咨詢
氧化 16837-52-8 HPLC≥98%;20mg 訂購(gòu)|咨詢
519-02-8 HPLC≥95%;20mg 訂購(gòu)|咨詢
苦杏仁苷 29883-15-6 HPLC≥98%;20mg 訂購(gòu)|咨詢
絞股藍(lán)皂苷 UV≥98%;20mg 訂購(gòu)|咨詢
金絲桃素 548-04-9 HPLC≥98%;10mg 訂購(gòu)|咨詢
金絲桃苷 482-36-0 HPLC≥98%;20mg 訂購(gòu)|咨詢
莪術(shù)醇 4871-97-0 HPLC≥98%;20mg 訂購(gòu)|咨詢
雙去氧基姜黃素 24939-16-0 HPLC≥98%;20mg 訂購(gòu)|咨詢
去甲氧基姜黃素 24939-17-1 HPLC≥98%;20mg 訂購(gòu)|咨詢
姜黃素 458-37-7 HPLC≥98%;20mg 訂購(gòu)|咨詢
71963-77-4 HPLC≥98%;20mg 訂購(gòu)|咨詢
槲皮苷 522-12-3 HPLC≥98%;20mg 訂購(gòu)|咨詢
槲皮素 117-39-5 HPLC≥98%;20mg 訂購(gòu)|咨詢
花旗松素;二氫槲皮素 480-18-2 HPLC≥98%;20mg 訂購(gòu)|咨詢
槐果堿 145572-44-7 HPLC≥98%;20mg 訂購(gòu)|咨詢
絡(luò)塞定 100462-37-1 HPLC≥98%;20mg 訂購(gòu)|咨詢
絡(luò)緦 85026-55-7 HPLC≥98%;10mg 訂購(gòu)|咨詢
5-fluoro SDB-006 (10 mg) N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide
5-fluoro SDB-006 (5 mg) N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide
PAF C-16 Carboxylic Acid (1 mg) CPAGP|Plaet-activating Factor C-16 Carboxylic Acid; 7-(acetyloxy)-24-carboxy-4-hydroxy-N,N,N-trimethyl-4-oxide-(R)-3,5,9-trioxa-4-phosphatetracosan-1-aminium
PAF C-16 Carboxylic Acid (10 mg) CPAGP|Plaet-activating Factor C-16 Carboxylic Acid; 7-(acetyloxy)-24-carboxy-4-hydroxy-N,N,N-trimethyl-4-oxide-(R)-3,5,9-trioxa-4-phosphatetracosan-1-aminium
PAF C-16 Carboxylic Acid (5 mg) CPAGP|Plaet-activating Factor C-16 Carboxylic Acid; 7-(acetyloxy)-24-carboxy-4-hydroxy-N,N,N-trimethyl-4-oxide-(R)-3,5,9-trioxa-4-phosphatetracosan-1-aminium
PAF C-16 Carboxylic Acid (500 ug) CPAGP|Plaet-activating Factor C-16 Carboxylic Acid; 7-(acetyloxy)-24-carboxy-4-hydroxy-N,N,N-trimethyl-4-oxide-(R)-3,5,9-trioxa-4-phosphatetracosan-1-aminium
BQCA (10 mg) 1,
BQCA (25 mg) 1,
BQCA (5 mg) 1,
BQCA (50 mg) 1,
Heat Shock Protein Inhibitor I (1 mg) HSP Inhibitor I|KNK 437; 3-(1,3-benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde
Heat Shock Protein Inhibitor I (10 mg) HSP Inhibitor I|KNK 437; 3-(1,3-benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde
Heat Shock Protein Inhibitor I (25 mg) HSP Inhibitor I|KNK 437; 3-(1,3-benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde
Heat Shock Protein Inhibitor I (5 mg) HSP Inhibitor I|KNK 437; 3-(1,3-benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde
ML-60218 (1 mg) 2-chloro-N-[3-(5-chloro-3-methylbenzo[b]thien-2-yl)-1-methyl-1H-pyrazol-5-yl]-benzenesulfonamide
ML-60218 (10 mg) 2-chloro-N-[3-(5-chloro-3-methylbenzo[b]thien-2-yl)-1-methyl-1H-pyrazol-5-yl]-benzenesulfonamide
ML-60218 (5 mg) 2-chloro-N-[3-(5-chloro-3-methylbenzo[b]thien-2-yl)-1-methyl-1H-pyrazol-5-yl]-benzenesulfonamide
Stauprimide (1 mg) N-Benzoyl-7-oxo Staurosporine; N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1,3-dioxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’,1’-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-benzamide
Stauprimide (5 mg) N-Benzoyl-7-oxo Staurosporine; N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1,3-dioxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’,1’-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-benzamide
Stauprimide (500 ug) N-Benzoyl-7-oxo Staurosporine; N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1,3-dioxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’,1’-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-benzamide
Xanthohumol (1 mg) (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
Xanthohumol (10 mg) (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
Xanthohumol (25 mg) (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
Xanthohumol (5 mg) (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
Zerumbone (10 mg) (2E,6E)-2,6,9,9-tetramethyl-2,6,10E-cycloundecatrien-1-one
Zerumbone (5 mg) (2E,6E)-2,6,9,9-tetramethyl-2,6,10E-cycloundecatrien-1-one
Zerumbone (50 mg) (2E,6E)-2,6,9,9-tetramethyl-2,6,10E-cycloundecatrien-1-one
PSI-7977 (1 mg) GI-7977|Sofosbuvir; N-[[P(S),2’R]-2’-deoxy-2’-fluoro-2’-methyl-P-phenyl-5’-uridylyl]-L-alanine 1-methylethyl ester
PSI-7977 (10 mg) GI-7977|Sofosbuvir; N-[[P(S),2’R]-2’-deoxy-2’-fluoro-2’-methyl-P-phenyl-5’-uridylyl]-L-alanine 1-methylethyl ester
PSI-7977 (5 mg) GI-7977|Sofosbuvir; N-[[P(S),2’R]-2’-deoxy-2’-fluoro-2’-methyl-P-phenyl-5’-uridylyl]-L-alanine 1-methylethyl ester
CAY10683 (10 mg) Santacruzamate A; N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-ethyl ester-carbamic acid
CAY10683 (25 mg) Santacruzamate A; N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-ethyl ester-carbamic acid
CAY10683 (5 mg) Santacruzamate A; N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-ethyl ester-carbamic acid
CAY10683 (50 mg) Santacruzamate A; N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-ethyl ester-carbamic acid
Amikacin (1 g) Antibiotic BB-K 8|BAY 41-6551|BB-K 8|Lukadin|Potentox; O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine
Amikacin (5 g) Antibiotic BB-K 8|BAY 41-6551|BB-K 8|Lukadin|Potentox; O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine
AZD 5363 (1 mg) 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
AZD 5363 (10 mg) 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
AZD 5363 (25 mg) 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
AZD 5363 (5 mg) 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
Budesonide (100 mg) Entocort|Pulmicort; 16α,
Budesonide (250 mg) Entocort|Pulmicort; 16α,
Budesonide (50 mg) Entocort|Pulmicort; 16α,
Budesonide (500 mg) Entocort|Pulmicort; 16α,
Metanephrine (10 mg) 4-hydroxy-3-methoxy-α-[(methylamino)methyl]-benzenemethanol
Metanephrine (5 mg) 4-hydroxy-3-methoxy-α-[(methylamino)methyl]-benzenemethanol
Metanephrine (50 mg) 4-hydroxy-3-methoxy-α-[(methylamino)methyl]-benzenemethanol
LY2109761 (1 mg) 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-quinoline
LY2109761 (10 mg) 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-quinoline
LY2109761 (5 mg) 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-quinoline
GW 2580 (1 mg) 5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-2,4-pyrimidinediamine